Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1189 to 1190 of 1190 entries
Sorted by: Best Match Show Resources per page
What We Learned in 25 Years of Interactive Molecular Design Sessions.

ChemMedChem

Kuhn B, Haap W, Obst-Sander U, Kramer C, Stahl M.
PMID: 34374230
ChemMedChem. 2021 Sep 16;16(18):2760-2763. doi: 10.1002/cmdc.202100351. Epub 2021 Aug 10.

We retrace Prof. François Diederich's consultancy work for Roche and its impact over the years he worked with us. François Diederich uniquely shaped our approach to molecular design, and interactions with him and his research group at ETH Zurich...

Cite
Kuhn B, Haap W, Obst-Sander U, et al. What We Learned in 25 Years of Interactive Molecular Design Sessions. ChemMedChem. 2021;16(18):2760-2763doi: 10.1002/cmdc.202100351.
Kuhn, B., Haap, W., Obst-Sander, U., Kramer, C., & Stahl, M. (2021). What We Learned in 25 Years of Interactive Molecular Design Sessions. ChemMedChem, 16(18), 2760-2763. https://doi.org/10.1002/cmdc.202100351
Kuhn, Bernd, et al. "What We Learned in 25 Years of Interactive Molecular Design Sessions." ChemMedChem vol. 16,18 (2021): 2760-2763. doi: https://doi.org/10.1002/cmdc.202100351
Kuhn B, Haap W, Obst-Sander U, Kramer C, Stahl M. What We Learned in 25 Years of Interactive Molecular Design Sessions. ChemMedChem. 2021 Sep 16;16(18):2760-2763. doi: 10.1002/cmdc.202100351. Epub 2021 Aug 10. PMID: 34374230.
Copy Download .nbib Format: NLM
Polypharmacy- Purpose, Benefits and Limitations.

Current medicinal chemistry

Grover D, Tom M, Maguire G, Stahl S.
PMID: 34994308
Curr Med Chem. 2022 Jan 07; doi: 10.2174/0929867329666220107153813. Epub 2022 Jan 07.

With what has become increasingly common among nearly all medical specialties, the number of patients who have various comorbid diseases both psychiatrically and mentally challenges the field of psychiatry. As a result, it is not uncommon physicians are imposed...

Cite
Grover D, Tom M, Maguire G, et al. Polypharmacy- Purpose, Benefits and Limitations. Curr Med Chem. 2022;doi: 10.2174/0929867329666220107153813.
Grover, D., Tom, M., Maguire, G., & Stahl, S. (2022). Polypharmacy- Purpose, Benefits and Limitations. Current medicinal chemistry, . https://doi.org/10.2174/0929867329666220107153813
Grover, Douglas, et al. "Polypharmacy- Purpose, Benefits and Limitations." Current medicinal chemistry vol. (2022). doi: https://doi.org/10.2174/0929867329666220107153813
Grover D, Tom M, Maguire G, Stahl S. Polypharmacy- Purpose, Benefits and Limitations. Curr Med Chem. 2022 Jan 07; doi: 10.2174/0929867329666220107153813. Epub 2022 Jan 07. PMID: 34994308.
Copy Download .nbib Format: NLM
Showing 1189 to 1190 of 1190 entries